Dr. Raj Mehra joins the podcast today to discuss the ongoing clinical trials that Seelos Therapeutics is conducting to investigate Racemic Ketamine as an effective drug candidate for treating patients with Acute Suicidal Ideation and Behavior -

The suicide crises in the United States and beyond is an epidemic in itself, and Seelos Therapeutics is working towards delivering the worlds first FDA-approved ketamine treatment for individuals with ASIB.

In this episode, Dr. Mehra discusses the clinical data suggesting that R-Ketamine is an effective treatment to help mitigate the suicide crises, as well as the Seelos Therapeutics patenting strategy and and path that a drug must take in order to be adapted into medicalized use.

Please consider rating and reviewing the podcast wherever you're listening.

Hosted on Acast. See acast.com/privacy for more information.